A previous epidemiological study [10] has shown that several clinical factors (female, no smoking history, adenocarcinoma, and East Asian ethnicity) are associated with a high prevalence of EGFR mutations; however, there are no robustly predictive clinical features of EGFR mutation status. Here, EGFR is linked to adenocarcinoma.